Sector: MedicalPharmaceutical Product Development, Inc. (NASDAQ: PPDI)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 242 |
Technical : | 52 |
Performance : | 194 |
Overall: | 193 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 246 |
Technical : | 57 |
Performance : | 215 |
Overall: | 209 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 247 |
Technical : | 110 |
Performance : | 232 |
Overall: | 237 |
Number of Stocks: | 305 |
Headlines
- PPD to Present at CHINATRIALS 2009
Nov 06, 2009 04:00 PM | PPDI
- PPD Completes Acquisition of Excel PharmaStudies
Nov 06, 2009 09:28 AM | PPDI
- PPDI: This Could Be the Biggest Biotech Trade Of 2010
Oct 30, 2009 10:05 AM | PPDI
- PPD Reports Third Quarter 2009 Financial Results; Updates 2009 Financial Guidance
Oct 27, 2009 05:10 PM | PPDI
- PPD Awarded U.S. Food and Drug Administration Contract to Evaluate FDA's Spontaneous Adverse Event Surveillance System
Oct 27, 2009 05:08 PM | PPDI
- PPD to Invest in Celtic Therapeutics
Oct 27, 2009 05:06 PM | PPDI
- PPD to Acquire Excel PharmaStudies
Oct 27, 2009 05:04 PM | PPDI
- PPD Announces Plans to Spin off Compound Partnering Business
Oct 27, 2009 05:02 PM | PPDI
- PPD Dermatology to Present at Second Annual Boston Biotech R&D Conference
Oct 21, 2009 04:23 PM | PPDI
- PPD Announces Third Quarter 2009 Earnings Release, Webcast and Conference Call
Sep 29, 2009 06:00 AM | PPDI
- PPD Declares Third Quarter Dividend
Aug 18, 2009 09:55 AM | PPDI
- PPD Named One of North Carolina’s Best Employers
Aug 05, 2009 04:30 PM | PPDI
- PPD Reports Second Quarter 2009 Financial Results
Jul 21, 2009 05:52 PM | PPDI
- BenchmarkJournal.Com Free Analyst Review for PCBC, SHLD, PPDI, SOHU, AMMD and TSTR
Jul 10, 2009 10:19 AM | AMMD, PCBC, PPDI, SHLD, SOHU, TSTR
- PPD Announces Second Quarter 2009 Earnings Release, Webcast and Conference Call
Jul 01, 2009 04:02 PM | PPDI
- PPD Confirms Takeda Receives FDA Complete Response for Alogliptin
Jun 29, 2009 08:59 AM | PPDI
- PPD Confirms Johnson & Johnson Pharmaceutical Research & Development’s Completion of Additional Phase III Studies Providing Expanded Safety and Efficacy Data for Priligy®
Jun 10, 2009 08:57 AM | PPDI
- PPD Announces Takeda to Conduct Additional Study for Alogliptin MAA in the EU
Jun 03, 2009 07:57 PM | PPDI
- PPD Increases Cash Dividend Rate for Fourth Consecutive Year; Declares Second Quarter Dividend
May 26, 2009 10:04 AM | PPDI
- PPD Promotes Fred Eshelman to Executive Chairman; Ernest Mario Assumes Role of Lead Independent Director; PPD Names David Grange as New Chief Executive Officer
May 19, 2009 05:59 PM | PPDI
- Form 4 Wilkinson Michael O. For: Jun 30 (10K)
Jul 15, 2009 06:06 PM
- Form 4 Sharbaugh William J For: Jun 30 (10K)
Jul 15, 2009 06:04 PM
- Form 4 Richardson William W For: Jun 30 (10K)
Jul 15, 2009 06:03 PM
- Form 4 ESHELMAN FREDRIC N For: Jun 18 (10K)
Jul 15, 2009 06:01 PM
- Form 4 MCNEILL JOHN A JR For: Jun 08 (10K)
Jul 15, 2009 06:00 PM
- Form 4 Darazsdi Daniel G For: Jun 30 (10K)
Jul 15, 2009 05:57 PM
- Form 4 GRANGE DAVID L For: Jul 01 (10K)
Jul 02, 2009 12:37 PM
- Form 4 MCNEILL JOHN A JR For: May 20 (10K)
May 22, 2009 01:27 PM
- Form 4 MARIO ERNEST For: Mar 03 (10K)
May 22, 2009 01:25 PM
- Form 4 MAGNUSON TERRY For: May 20 (10K)
May 22, 2009 01:22 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
PPDI
|
Compare to S&P
|
| YTD |
-25.72 %
|
-35.25 %
|
| 4 Weeks |
0.37 %
|
-0.69 %
|
| 12 Weeks |
4.56 %
|
1.97 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 3.03 %
|
|
EPS Growth in Last Year: -22.73 %
|
|
Sales Growth in Last Quarter: -3.99 %
|
|
Sales Growth in Last Quarter: -14.41 %
|
|
